“…The clinical relevance of VSA has been noted across a spectrum of disorders affecting communication, including: (1) children with neurogenic speech disorders (Higgins & Hodge, 2002; Hustad, Gorton, & Lee, 2010; Liu, Tsao, & Kuhl, 2005; Narasimhan, Nikitha, & Francis, 2016); (2) adults with acquired dysarthria (Bang, Min, Sohn, & Cho, 2013; S. Kim, Kim, & Ko, 2014; Turner, Tjaden, & Weismer, 1995; Weismer, Jeng, Laures, Kent, & Kent, 2001); (3) adults with Down syndrome (Bunton & Leddy, 2011), (4) individuals with hearing loss (Palethorpe & Watson, 2003); (5) individuals with hearing loss (Palethorpe & Watson, 2003); (6) adults who have undergone glossectomy (Kaipa, Robb, O’Beirne, & Allison, 2012; Whitehill, Ciocca, Chan, & Samman, 2006); (7) adults who have undergone glossectomy (Kaipa, Robb, O’Beirne, & Allison, 2012; Takatsu et al 2017; Whitehill, Ciocca, Chan, & Samman, 2006); (8) individuals undergoing treatment for oral or oropharyngeal cancer (de Bruijn et al, 2009); (9) individuals with Class III malocclusion (Xue, Lam, Whitehill, & Samman, 2011); (8) people who stutter (Blomgren, Robb, & Chen, 1998; Hirsch et al, 2008); (9) individuals with hypernasality associated with cleft palate (Haque, Ali, & Haque, 2016); and (10) individuals in psychological distress or with self-reported symptoms of depression and post-traumatic stress disorder (Scherer, Lucas, Gratch, Rizzo, & Morency, in press; Scherer, Morency, Gratch, & Pestian, 2015).…”